Feng Meng
Impact in
- Hematology top 5%
- Chronic Myeloid Leukemia Treatments
-
- Cancer Immunotherapy and Biomarkers
- Cancer Cells and Metastasis
Papers in
-
- Chronic Myeloid Leukemia Treatments 5
- Oncology 3
- Cancer Immunotherapy and Biomarkers 3
- Co-authors
- Ji Yuan Wu (5 shared papers)Nicholas J. Donato (5 shared papers)Moshe Talpaz (5 shared papers)Zhenghong Peng (2 shared papers)William G. Bornmann (2 shared papers)Mourad Majidi (5 shared papers)Jack A. Roth (4 shared papers)Ismail Mustafa Meraz (3 shared papers)
- Journals
- Blood (3 papers)Communications Biology (2 papers)Thrombosis and Haemostasis (1 paper)Molecular Cancer Therapeutics (1 paper)Cancer Immunology Research (1 paper)
- Partner nations
- United StatesJapanSouth Korea
In The Last Decade
Feng Meng
15 papers receiving 552 citations
Peers
Comparison fields: 5 of 56
- Hematology 192
- Oncology 124
- Geriatrics and Gerontology 18
- Genetics 64
- Molecular Medicine 12
Countries citing papers authored by Feng Meng
This map shows the geographic impact of Feng Meng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Feng Meng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Feng Meng more than expected).
Fields of papers citing papers by Feng Meng
This network shows the impact of papers produced by Feng Meng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Feng Meng. The network helps show where Feng Meng may publish in the future.
Co-authors
The 25 scholars most cited alongside Feng Meng, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 134 | |
| 2 | 2019 | 124 | |
| 3 | 2008 | 90 | |
| 4 | Effective therapy of metastatic ovarian cancer with an oncolytic herpes simplex virus incorporating two membrane fusion mechanisms. | 2003 | 56 |
| 5 | 2002 | 32 | |
| 6 | 2011 | 30 | |
| 7 | 2002 | 29 | |
| 8 | 2015 | 28 | |
| 9 | 2022 | 15 | |
| 10 | 2017 | 9 | |
| 11 | 2005 | 7 | |
| 12 | 2023 | 5 | |
| 13 | 2025 | 4 | |
| 14 | 2008 | 2 | |
| 15 | 2004 | 1 |
About Feng Meng
Feng Meng is a scholar working on Hematology, Oncology, Geriatrics and Gerontology, Pulmonary and Respiratory Medicine and Neurology, having authored 15 papers that have together received 566 indexed citations. Recurring topics across this work include Chronic Myeloid Leukemia Treatments (5 papers), Cancer Immunotherapy and Biomarkers (3 papers), Lung Cancer Treatments and Mutations (2 papers), Neurofibromatosis and Schwannoma Cases (1 paper), RNA Interference and Gene Delivery (1 paper), Sirtuins and Resveratrol in Medicine (1 paper), Virus-based gene therapy research (1 paper) and Nuclear Receptors and Signaling (1 paper). The work is most often cited by research in Hematology (192 citations), Oncology (124 citations), Geriatrics and Gerontology (18 citations), Genetics (64 citations) and Molecular Medicine (12 citations). Feng Meng has collaborated with scholars based in United States, Japan and South Korea. Frequent co-authors include Ji Yuan Wu, Nicholas J. Donato, Moshe Talpaz, Zhenghong Peng, William G. Bornmann, Mourad Majidi, Jack A. Roth, Ismail Mustafa Meraz, Elizabeth J. Shpall and Ling-Yuan Kong. Their work appears in journals such as Blood, Communications Biology, Thrombosis and Haemostasis, Molecular Cancer Therapeutics and Cancer Immunology Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.